Role of ERK1/2 and JNK phosphorylation in iodine contrast agent-induced apoptosis in diabetic rat kidneys

References

• Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–195
   PubMed Web of Science ®Google Scholar
• Finn WF. The clinical and renal consequences of contrast-induce nephropathy. Nephrol Dial Transplant. 2006;21:i2–i10
   PubMedGoogle Scholar
• Mautone A, Brown JR. Contrast-induced nephropathy in patients undergoing elective and urgent procedures. J Interv Cardiol. 2010;23:78–85
   PubMed Web of Science ®Google Scholar
• Katzberg RW, Haller C. Contrast-induced nephrotoxicity: Clinical landscape. Kidney Int Suppl. 2006;100:S3–S7
   PubMedGoogle Scholar
• Reed PS, Boura JA, O'Neill WW, Kahn JK. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. Am J Cardiol. 2007;100:1090–1093
   PubMed Web of Science ®Google Scholar
• Zaytseva NV, Shamkhalova MS, Shestakova MV, et al. Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic value. Diabetes Res Clin Pract. 2009;86(Suppl 1):S63–S69
   PubMed Web of Science ®Google Scholar
• Fanning NF, Manning BJ, Buckley J, Redmond HP. Iodinated contrast media induce neutrophil apoptosis through a mitochondrial and caspase mediated pathway. Br J Radiol. 2002;75:861–873
   PubMed Web of Science ®Google Scholar
• Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol. 2001;280:F61–F70
   PubMed Web of Science ®Google Scholar
• Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kidney Int. 2003;64:128–139
   PubMed Web of Science ®Google Scholar
• Briguori C, Tavano D, Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis. 2003;45:493–503
   PubMed Web of Science ®Google Scholar
• Wasaki M, Sugimoto J, Shirota K. Glucose alters the susceptibility of mesangial cells to contrast media. Invest Radiol. 2001;36:355–362
   PubMed Web of Science ®Google Scholar
• O'Donnell DH, Moloney MA, Bouchier-Hayes DJ, Lee MJ. Contrast-induced nephrotoxicity: Possible synergistic effect of stress hyperglycemia. AJR Am J Roentgenol. 2010;195:W45–W49
   PubMed Web of Science ®Google Scholar
• Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors. 2003;17:287–296
   PubMed Web of Science ®Google Scholar
• Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal. 2002;4:405–414
   PubMed Web of Science ®Google Scholar
• Yang JY, Michod D, Walicki J, Widmann C. Surviving the kiss of death. Biochem Pharmacol. 2004;68:1027–1031
   PubMed Web of Science ®Google Scholar
• Lee HC, Sheu SH, Yen HW, Lai WT, Chang JG. JNK/ATF2 Pathway is involved in iodinated contrast media-induced apoptosis. Am J Nephrol. 2010;31:125–133
   PubMed Web of Science ®Google Scholar
• Lee HC, Chang JG, Yen HW, Liu IH, Lai WT, Sheu SH. Ionic contrast media induced more apoptosis in diabetic kidney than nonionic contrast media. J Nephrol. 2011;24:376–380
   PubMed Web of Science ®Google Scholar
• Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol. 2004;287:F543–F549
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim HJ, Kwon CH, et al. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol. 2005;25:374–382
   PubMed Web of Science ®Google Scholar
• Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem. 2002;277:43377–43388
   PubMed Web of Science ®Google Scholar
• Maioli M, Toso A, Gallopin M, et al. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med (Hagerstown). 2010;11:444–449
   PubMed Web of Science ®Google Scholar
• Toprak O, Cirit M, Yesil M, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007;22:819–826
   PubMed Web of Science ®Google Scholar
• Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: Hypertonic versus oxidative stress. Invest Radiol. 2002;37:428–434
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Kuhlmann MK, Kohlbacher S, et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: In vitro study. Radiology. 2007;242:425–434
   PubMed Web of Science ®Google Scholar
• Beeri R, Symon Z, Brezis M, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int. 1995;47:1806–1810
   PubMed Web of Science ®Google Scholar
• Yano T, Itoh Y, Sendo T, Kubota T, Oishi R. Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase. Kidney Int. 2003;64:2052–2063
   PubMed Web of Science ®Google Scholar
• Romano G, Briguori C, Quintavalle C, et al. Contrast agents and renal cell apoptosis. Eur Heart J. 2008;29:2569–2576
   PubMed Web of Science ®Google Scholar
• Yano T, Itoh Y, Kubota T, et al. A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein. Am J Pathol. 2005;166:1333–1342
   PubMed Web of Science ®Google Scholar
• Kolyada AY, Liangos O, Madias NE, Jaber BL. Protective Effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol. 2008;28:203–209
   PubMed Web of Science ®Google Scholar